This site is intended for health professionals only

Wednesday 19 June 2019
Share |

Topic: msd

January 31, 2018
Letermovir is a first-in-class antiviral drug that inhibits cytomegalovirus replication

January 12, 2018
Bezlotoxumab is the first EC licensed non-antibiotic option indicated to prevent Clostridium difficile infection recurrence in high-risk adults